Dietrich John Pauls insider trades

Open-market stock purchases and sales by Dietrich John Pauls, President & CEO at DiaMedica Therapeutics Inc, from SEC Form 4 filings since Dec 11, 2018.

Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +100%.

Recent trades

DateStockTradeValue
Aug 10, 2026DMAC DiaMedica Therapeutics IncBought (not open market)—
Jun 1, 2026DMAC DiaMedica Therapeutics IncBought (not open market)—

Companies traded

  • DMAC DiaMedica Therapeutics Inc: 4 buys, last Aug 10, 2026
  • DMAX DiaMedica Therapeutics Inc: 1 buy, last Nov 16, 2022

Get free alerts when Dietrich John Pauls files a new trade →